Lmr Partners LLP Otonomy, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.06 - $2.67 $24,715 - $32,034	-11,998 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.49 - $6.23 $29,875 - $74,747	11,998 New	11,998 $31,000
Q4 2018 Feb 14, 2019	SELL	$1.51 - $2.93 $79,654 - $154,560	-52,751 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.95 $115,172 - $174,973	-44,297 Reduced 45.64%	52,751 $145,000
Q2 2018 Aug 03, 2018	BUY	$3.7 - $4.75 $359,077 - $460,978	97,048 New	97,048 $374,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.